Literature DB >> 26695436

The effect of platelet-rich plasma on the outcome of short-term narrowband-ultraviolet B phototherapy in the treatment of vitiligo: a pilot study.

Zeinab A Ibrahim1, Amal A El-Ashmawy1, Rania A El-Tatawy1, Fersan A Sallam2.   

Abstract

BACKGROUND: Narrowband - ultraviolet B (NB-UVB) is an emerging, effective, and safe therapy for vitiligo, but the treatment course often requires a long duration of time which may carry a potential risk for various side effects and patients' noncompliance.
OBJECTIVE: To explore the effect of platelet-rich plasma (PRP) injection on the outcome of short-term NB-UVB therapy for the patients with stable vitiligo. PATIENTS AND METHODS: The study included 60 stable vitiligo patients with overall symmetrical lesions. For each patient, the left side of the body was treated with NB-UVB alone (control side) while the right side was treated with NB-UVB therapy in addition to intradermal injection of PRP, every 2 weeks for 4 months.
RESULTS: There was statistically highly significant improvement in the repigmentation in the combination group(PRP plus NB-UVB) compared with NB-UVB group.
CONCLUSION: Intradermal PRP injection in combination with NB-UVB could be considered as a simple, safe, tolerable, and cheap technique for treatment of vitiligo. It shortens the duration of NB-UVB therapy and is expected to increase patient compliance. Longer follow-up is needed.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  narrow-band UVB; platelet-rich plasma; vitiligo

Mesh:

Year:  2015        PMID: 26695436     DOI: 10.1111/jocd.12194

Source DB:  PubMed          Journal:  J Cosmet Dermatol        ISSN: 1473-2130            Impact factor:   2.696


  9 in total

Review 1.  Progress in the Use of Platelet-rich Plasma in Aesthetic and Medical Dermatology.

Authors:  Mao-Ying Lin; Chrang-Shi Lin; Sindy Hu; Wen-Hung Chung
Journal:  J Clin Aesthet Dermatol       Date:  2020-08-01

Review 2.  Platelet-Rich Plasma: A Comprehensive Review of Emerging Applications in Medical and Aesthetic Dermatology.

Authors:  Christopher White; Allyson Brahs; David Dorton; Kristin Witfill
Journal:  J Clin Aesthet Dermatol       Date:  2021-11

Review 3.  The Usefulness of Platelet-Rich Plasma (PRP) for the Treatment of Vitiligo: State of the Art and Review.

Authors:  S R Mercuri; L Vollono; G Paolino
Journal:  Drug Des Devel Ther       Date:  2020-05-07       Impact factor: 4.162

4.  Platelet-rich plasma versus combined fractional carbon dioxide laser with platelet-rich plasma in the treatment of vitiligo: a comparative study.

Authors:  Mostafa Kadry; Abeer Tawfik; Noha Abdallah; Ashraf Badawi; Hisham Shokeir
Journal:  Clin Cosmet Investig Dermatol       Date:  2018-11-08

Review 5.  Platelets in Skin Autoimmune Diseases.

Authors:  Xiaobo Liu; Christian Gorzelanny; Stefan W Schneider
Journal:  Front Immunol       Date:  2019-07-04       Impact factor: 7.561

6.  Platelet-rich plasma, a promising adjunctive treatment for vitiligo: A case report.

Authors:  Lu Yin; Prince Adotama; Katerina Svigos; Daniel Gutierrez; Kristen Lo Sicco
Journal:  JAAD Case Rep       Date:  2020-10-08

7.  Fractional Carbon Dioxide Laser versus Fractional Carbon Dioxide Laser with Autologous Intralesional Platelet-rich Plasma in the Treatment of Stable, Non-segmental Vitiligo: A Randomized Comparative Study.

Authors:  Annie Raizada; Maitreyee Panda; Bhabani Stp Singh; Bikash R Kar
Journal:  J Cutan Aesthet Surg       Date:  2021 Jan-Mar

8.  Meta-analysis of the efficacy of adding platelet-rich plasma to 308-nm excimer laser for patients with vitiligo.

Authors:  Jiaoquan Chen; Nanji Yu; Huaping Li; Yi Tang; Huilan Zhu
Journal:  J Int Med Res       Date:  2022-09       Impact factor: 1.573

9.  A Simple Drug Delivery System for Platelet-Derived Bioactive Molecules, to Improve Melanocyte Stimulation in Vitiligo Treatment.

Authors:  Karolina Vocetkova; Vera Sovkova; Matej Buzgo; Vera Lukasova; Radek Divin; Michala Rampichova; Pavel Blazek; Tomas Zikmund; Jozef Kaiser; Zdenek Karpisek; Evzen Amler; Eva Filova
Journal:  Nanomaterials (Basel)       Date:  2020-09-10       Impact factor: 5.076

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.